Session » Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)

Date: Saturday, November 6, 2021

Time: 8:30AM-10:30AM

Meeting: ACR Convergence 2021

8:30AM-10:30AM: Abstract Number: 0251

A Comparative Study of the Validity of the DAS28-ESR and JADAS-27 Disease Activity Assessment Indexes for Juvenile Idiopathic Arthritis in Transition and Adults

8:30AM-10:30AM: Abstract Number: 0257

Can We Assess Disability in Juvenile Idiopathic Arthritis with Two Simple Questions? Results from the CAPRI Registry

8:30AM-10:30AM: Abstract Number: 0256

Consensus Approach to a Treat to Target Strategy in Juvenile Idiopathic Arthritis Care: Report from the 2020 Pediatric Rheumatology Care and Outcomes Improvement Network Consensus Conference

8:30AM-10:30AM: Abstract Number: 0258

Developing Electronic Health Record Algorithms That Accurately Identify Patients with Juvenile Idiopathic Arthritis

8:30AM-10:30AM: Abstract Number: 0265

Development and Preliminary Acceptability of JIActiv, a Social Media-Based Program Promoting Engagement in Physical Activity Among Young People Living with Juvenile Idiopathic Arthritis

8:30AM-10:30AM: Abstract Number: 0244

Development of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration

8:30AM-10:30AM: Abstract Number: 0243

Effectiveness of Abatacept in Patients with JIA, Classified by Category: Results from the PRCSG/PRINTO JIA Real-World Registry

8:30AM-10:30AM: Abstract Number: 0242

FiRst Line Options for Systemic JIA Treatment (FROST): Results from a Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry Consensus Treatment Plan Observational Study

8:30AM-10:30AM: Abstract Number: 0262

High Degree of Inter-patient Heterogeneity in Synoviocyte Hyperplasia and Immune Cells Infiltration in the Synovium of Juvenile Idiopathic Arthritis Patients

8:30AM-10:30AM: Abstract Number: 0255

Identification of Tolerated Disease Activity Level for Individuals with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry

8:30AM-10:30AM: Abstract Number: 0260

Impact on Caregivers of Patients with Juvenile Idiopathic Arthritis: A Hospital-based Study from India

8:30AM-10:30AM: Abstract Number: 0250

Is There a Need for a New Classification Criteria in Juvenile Spondyloarthritis?

8:30AM-10:30AM: Abstract Number: 0259

JIA Diagnoses and Trends from 2006-2019: Has the U.S. ICD-9-to-ICD-10 Transition Created Coding Artifacts?

8:30AM-10:30AM: Abstract Number: 0264

Joint Acoustic Emissions as a Biomarker to Differentiate Between Active and Inactive Juvenile Idiopathic Arthritis via 2-stage Machine Learning Classifier

8:30AM-10:30AM: Abstract Number: 0245

Long-term Safety and Effectiveness of Abatacept Treatment in Patients with JIA: 5-year Results from the PRCSG/PRINTO JIA Real-World Registry

8:30AM-10:30AM: Abstract Number: 0246

Macrophage Activating Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Biological Drugs

8:30AM-10:30AM: Abstract Number: 0261

Methotrexate Withdrawal and Outcomes in Participants with Well-controlled Non-systemic JIA Within the CARRA Registry

8:30AM-10:30AM: Abstract Number: 0249

Open-label, Long-term (10-year) Study of the Safety of Etanercept in Children with Extended Oligoarticular Arthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis

8:30AM-10:30AM: Abstract Number: 0254

Patient and Disease-Level Factors Associated with Sustained Cessation of Medication for Disease Remission in Systemic Juvenile Idiopathic Arthritis

8:30AM-10:30AM: Abstract Number: 0263

Patterns of Medication Switching in Juvenile Idiopathic Arthritis: A Retrospective Analysis of a National Administrative Claims Database

8:30AM-10:30AM: Abstract Number: 0248

Proportion of Patients with a Polyphasic Disease Course in Systemic-onset Juvenile Idiopathic Arthritis May Be Higher in the Age of Cytokine Inhibitors

8:30AM-10:30AM: Abstract Number: 0241

Psoriasis Rate Is Increased by the Exposure to TNF Inhibition in Children with JIA

8:30AM-10:30AM: Abstract Number: 0253

Rheumatoid Factor Status as a Predictor of Disease Activity and Disability:An Analysis of the New CARRA Registry Polyarticular Juvenile Idiopathic Arthritis Cohort

8:30AM-10:30AM: Abstract Number: 0252

Role of Clinical and Laboratory Parameters in Differentiating Infection from Disease Flare in Febrile Patients of Systemic Juvenile Idiopathic Arthritis

8:30AM-10:30AM: Abstract Number: 0247

Three-year Effectiveness in Patients with JIA Initiating Abatacept: Results from the PRCSG/PRINTO JIA Real-World Registry

« View all sessions from this meeting